VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...
Could inhaling xenon gas help fight Alzheimer’s disease? In the January 15 Science Translational Medicine, scientists led by Oleg Butovsky at Brigham and Women’s Hospital, Boston, and David Holtzman ...
Share on Pinterest Scientists are investigating xenon gas as a potential treatment for Alzheimer’s. Westend61/Getty Images Researchers continue to search for effective treatments for Alzheimer ...
Xenon Pharmaceuticals' Azetukalner has good Phase 2 data for MDD using Kv7 potassium channels. This also gives it a good safety profile. The company has robust financials with a runway that should ...
The study found that Xenon gas inhalation suppressed neuroinflammation, reduced brain atrophy, and increased protective neuronal states in mouse models of Alzheimer's disease. Results are ...
Scientists found inhaling xenon boosted brain health and improved problem-solving skills, which could potentially help combat the currently incurable disease. Xenon is an extremely expensive gas ...
Xenon gas emerges as a promising treatment for Alzheimer’s, showing benefits in preclinical tests such as reducing brain atrophy and enhancing neuron protection, with human trials starting soon. A ...
Xenon gas inhalation shows potential in treating Alzheimer's disease by reducing neuroinflammation, brain atrophy, and enhancing protective neuronal states in mouse models.
The study found that Xenon gas inhalation suppressed neuroinflammation, reduced brain atrophy, and increased protective neuronal states in mouse models of Alzheimer's disease. A phase 1 clinical ...
The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.
Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial
New research from Mass General Brigham and Washington University School of Medicine in St. Louis found Xenon gas inhalation reduced neurodegeneration and boosted protection in preclinical models o ...
Xenon Pharmaceuticals provided an update on its pipeline programs, highlighting significant progress and upcoming milestones for 2025. The company anticipates topline data from its first Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback